DENTSPLY SIRONA Inc. Profile Avatar - Palmy Investing

DENTSPLY SIRONA Inc.

DENTSPLY SIRONA Inc. manufactures and sells various dental products and technologies for professional dental market worldwide. The company operates through two segments, Technologies & Equipment, and Consumables. The Technologies & Equipment segment prov…
Medical - Instruments & Supplies
US, Charlotte [HQ]

Ratios

15 Sheets · Starting from 2023
Margins, Growth Rates In %
Ratio 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Profitability
Gross Margin
51.45 50.88 50.18 53.15 53.46 54.74 56.73 53.42 54.80 51.87 53.74 49.58 55.54 54.23 52.69
Profit Margin
12.70 11.96 9.64 10.73 10.61 11.05 9.39 11.48 -39.39 -25.36 6.52 -2.48 9.67 -24.22 -3.33
Operating Margin
17.65 17.12 11.85 13.04 14.21 15.25 14.03 12.14 -39.70 -24.03 12.96 13.64 14.63 7.80 7.44
EPS Growth
-2.63 - - -6.49 28.32 -0.90 3.64 -21.49 10.06 -448.22 34.26 126.16 -132.20 594.74 -334.57 85.94
Return on Assets (ROA)
8.88 8.16 5.14 6.32 6.17 6.94 5.71 3.69 -15.15 -11.64 3.06 -0.89 4.46 -12.43 -1.79
Return on Equity (ROE)
14.97 14.45 13.23 14.23 12.35 13.91 10.74 5.30 -23.73 -19.74 5.16 -1.67 8.15 -24.92 -4.01
Return on Invested Capital (ROIC)
12.51 11.64 8.68 9.96 8.97 9.93 8.24 4.61 -18.54 -14.91 5.98 8.55 6.43 4.67 4.07
Solvency
Equity Ratio
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Debt/Assets
15.20 18.78 37.15 30.59 29.07 27.22 26.19 13.15 15.82 19.08 18.07 25.77 24.30 27.39 29.50
Debt/Equity
25.62 33.26 95.60 68.86 58.23 54.53 49.32 18.88 24.76 32.36 30.52 48.43 44.42 54.91 66.02
Debt/EBITDA
-16.29 15.91 419.76 263.49 244.74 214.05 169.72 145.86 49.41 67.85 136.08 249.24 189.72 272.56 307.99
Debt/Capitalization
20.39 24.96 48.87 40.78 36.80 35.29 33.03 15.88 19.85 24.45 23.38 32.63 30.76 35.44 39.77
Interest Debt per Share USD
3.28 4.42 12.81 11.12 10.69 9.26 8.64 7.19 7.33 7.56 7.10 11.20 10.51 9.99 10.56
Debt Growth
-13.87 56.02 146.68 -17.99 -4.57 -1.14 -1.03 32.44 6.65 2.84 -6.18 54.80 -6.94 -6.56 9.84
Liquidity
Current Ratio
273.94 365.20 139.89 119.76 143.62 184.67 251.41 244.18 211.55 186.32 200.89 135.99 154.89 161.79 138.46
Quick Ratio
179.75 245.73 69.72 56.56 70.77 97.30 149.71 134.11 118.44 102.61 123.24 86.86 93.42 87.26 78.81
Cash Ratio
101.30 149.97 10.65 8.64 9.41 23.20 59.79 49.79 33.87 30.55 40.67 33.26 28.58 31.20 23.44
Operating Cash Flow Ratio
- - 100 - - - - - - - - 100 - - - - - - - - - - - - - - - -
Turnover
Inventory Turnover
359.56 353.33 349.48 340.51 313.15 341.73 339.92 337.34 289.67 320.34 331.87 361.59 375.00 286.28 300.64
Receivables Turnover
619.45 644.15 593.33 661.92 624.10 685.09 668.74 588.88 535.17 567.93 515.24 496.58 569.08 620.57 524.47
Payables Turnover
1,039.81 952.89 847.84 830.08 1,034.24 997.53 866.09 782.24 634.63 675.77 605.42 552.46 705.22 643.37 615.08
Asset Turnover
69.95 68.17 53.36 58.89 58.11 62.85 60.74 32.13 38.47 45.89 46.84 35.77 46.11 51.31 53.80
Coverage
Interest Coverage
2,137.78 1,515.70 674.02 671.82 844.67 949.90 671.20 1,266.57 -4,139.16 -2,568.63 1,776.53 950.00 1,130.91 510.00 460.94
Asset Coverage
600 400 200 200 300 200 200 500 400 300 300 200 200 200 200
Cash Flow Coverage (CFGR)
77.24 59.23 22.27 24.31 28.31 44.28 43.14 36.77 36.66 30.16 40.70 26.38 29.33 24.70 17.34
EBITDA Coverage
2,100 1,600 700 700 800 900 900 2,100 6,800 5,300 2,800 1,600 1,800 1,000 900
Dividend Coverage
-900 -900 -800 -900 -800 -800 -600 -600 2,000 1,200 -300 - - -400 900 100
Time Interest Earned (TIE)
100 100 100 100 100 100 100 100 100 100 100 100 100 100 100
Market Prospects
Dividend Yield
0.57 0.59 0.58 0.56 0.50 0.50 0.47 0.51 0.52 0.94 0.64 0.77 0.76 1.52 1.54
Earnings Yield
5.26 5.40 4.94 5.59 4.53 4.28 2.95 3.42 -10.42 -12.12 2.08 -0.72 3.37 -13.85 -1.75
Price/Earnings (P/E)
1,902.00 1,851.58 2,023.19 1,788.18 2,208.90 2,338.01 3,391.32 2,927.46 -959.58 -825.06 4,802.29 -13,828.09 2,964.61 -722.27 -5,715.97
Price/Book (P/B)
284.72 267.47 267.69 254.39 272.90 325.18 364.37 155.10 227.67 162.89 247.80 230.93 241.61 180.00 229.12
Price/Sales (P/S)
241.51 221.51 194.94 191.87 234.45 258.27 318.55 336.02 377.98 209.25 313.34 343.43 286.63 174.95 190.29
Price/Cash Flow (P/CF)
1,439.04 1,357.84 1,257.30 1,519.86 1,655.66 1,346.96 1,712.71 2,233.78 2,507.75 1,668.93 1,995.14 1,807.45 1,854.57 1,327.18 2,001.35
End of XRAY's Analysis
CIK: 818479 CUSIP: 24906P109 ISIN: US24906P1093 LEI: - UEI: -
Secondary Listings
XRAY has no secondary listings inside our databases.